Lv4
510 积分 2023-03-02 加入
Asynchronous blockade of PD-L1 and CD155 by polymeric nanoparticles inhibits triple-negative breast cancer progression and metastasis
29天前
已完结
TIGIT antibody with PVR competitive ability enhances cancer immunotherapy and capable of eliciting anti-tumour immune memory
1个月前
已完结
Dynamic reprogramming of the tumor immune network via multicycle checkpoint degradation for cancer immunotherapy
1个月前
已完结
TRIM11 potentiates antitumor immunity via inhibition of the IFN-γ/PD-L1 axis
1个月前
已完结
TRIM11 potentiates antitumor immunity via inhibition of the IFN-γ/PD-L1 axis
1个月前
已完结
Modulating the tumor immune phenotypes by radiotherapy: formulating and validating the combination therapy of radiation, PD-L1, and TIM-3 blockade in colorectal cancer
2个月前
已完结
HIF-1–mediated ISG20 expression promotes breast cancer stemness and immune evasion
3个月前
已完结
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study
4个月前
已完结
The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation
4个月前
已完结
Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1
4个月前
已完结